SSSimon M. Scheck

Simon M. Scheck

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simon M. Scheck has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spectral flow cytometry of plasma and cervicovaginal fluid extracellular vesicles for diagnostic endometriosis biomarkers

    by E. S. J. Paterson, S. Scheck, S. McDowell, G. Roopi, N. Bedford, J. E. Girling, C. E. Henry

    Introduction: Evidence for the role of extracellular vesicles (EVs) in endometriosis pathophysiology suggests EVs may be a novel avenue for biomarker exploration. This study employed small particle flow cytometry to investigate plasma EVs with endometrial stromal cell markers and cervicovaginal fluid EVs with immunological receptors as diagnostic biomarkers of endometriosis. Methods: Blood and cervicovaginal fluid were collected from consenting patients undergoing surgery for suspected endometriosis. EVs were isolated from plasma ( n = 15 per group) and cervicovaginal fluid ( n = 20 per group), stained overnight with antibody probes, labelled with Aco-430 membrane stain then analysed by flow cytometry (Cytek Aurora). The proportions and antigen density of positive EVs were compared between people with endometriosis and symptomatic controls. Results: Measuring triple-positive EVs was deemed unsuitable given the variability in staining when multiplexing antibodies. Small proportions of antigen positive EVs were detected for all proteins investigated, however, no differences were observed for CD10 + , CD90 + , CD10 + CD90 + and CD140b + plasma EVs, or CCR2 + , CD55 + , CD59 + and CD82 + cervicovaginal fluid EVs. Conclusions: Although the EV populations did not distinguish endometriosis from symptomatic controls, this study provides valuable methodological insights into EV phenotyping to support future biomarker research and advance understanding of EV-mediated mechanisms in endometriosis.

  • Letter to the Editor

    by Hayley Mallinder, Erin Nesbitt‐Hawes, Simon Scheck, Michael Wynn‐Williams, Anusch Yazdani, Luk Rombauts, Jason A Abbott


  • Open Access

    Non‐invasive tests for endometriosis are here; how reliable are they, and what should we do with the results?

    by Simon M. Scheck, Claire Henry, Nick Bedford, Jason Abbott, Michael Wynn‐Williams, Anusch Yazdani, Simon McDowell

    A reliable non‐invasive biomarker for endometriosis is highly likely in the coming years. In the lead‐up to this, clinicians need to be aware of commercially available tests as they become accessible, be aware of the level of evidence to support them and be prepared to counsel and manage patients who present with the results of such tests. One such test gaining popularity in Europe was developed using a machine‐based learning algorithm to analyse thousands of microRNAs based on a 200‐patient cohort with suspected endometriosis in France. We explore the background science for this commercially available test; outline the questions that remain to be answered; and caution against its use outside of a research setting.


  • Open Access

    Retrospective review of endometriosis surgery at Te Whatu Ora – Capital and Coast

    by Emily S. J. Paterson, Simon Scheck, Simon McDowell, Nicholas Bedford, Jane E. Girling, Claire E. Henry

    Introduction: Endometriosis is an under‐researched disease, with Aotearoa‐specific data severely lacking. Current estimates of parameters such as rates of endometriosis diagnosis, indication for surgery and sites of disease are based on international data. There is currently no published data on endometriosis surgeries in Aotearoa New Zealand.Aims: We aimed to describe the laparoscopic surgeries conducted for suspected endometriosis at Te Whatu Ora – Capital and Coast, including the prevalence of endometriosis in this cohort, indication for surgery, symptoms experienced, endometriosis stage and sites involved, number of repeat laparoscopies, and prevalence of endometriosis at repeat surgery.Materials and methods: To conduct this retrospective cross‐sectional study, data were extracted from Te Whatu Ora – Capital and Coast systems to identify all records indicating surgery for suspected endometriosis during 2018 and 2019. Variables investigated included age, ethnicity, endometriosis diagnosis (International Classification of Diseases‐10 Clinical Modification coding), stage of endometriosis, histological report and endometriosis symptoms (pain and/or fertility).Results: There were 436 surgeries for suspected endometriosis performed during 2018 and 2019, and endometriosis was diagnosed in 68.3% of these surgeries. Pacific and Asian people were under‐represented in the study cohort compared to the demographics of the hospital catchment area (Pacific: 3.0% vs 8.4%, Asian: 9.9% vs 12.9%). The most common indication for surgery was pain. There were 76 surgeries performed for suspected recurrence of endometriosis, and endometriosis was identified in 55.6% of these.Conclusions: Endometriosis surgeries in this hospital in Aotearoa show similar presentations and surgical findings to international data. Our findings highlight areas requiring more research in an Aotearoa‐specific context.


  • Open Access

    A survey exploring the use of symptom diary mobile apps for endometriosis

    by Simon M Scheck, Bryndl Hohmann-Marriott, Gary Faughnan, Claire Henry

    Background: Symptom tracking for endometriosis has been validated with clinical benefits, however, there is limited evidence around the use of mobile apps for endometriosis symptom tracking. Method: We performed a survey of people with suspected or confirmed endometriosis in Aotearoa New Zealand to assess mobile app use for symptom tracking including which app is being used, how frequently symptoms are tracked, which features are most important and which features would be desired. We also explored willingness to share symptom data with clinicians and/or researchers. Results: A total of 188 survey responses were included. Mobile apps were used for symptom tracking by 83/188 (44.1%), with only 13 of 188 (6.9%) reporting they would not consider use of an app. Of current app users, 51.5% reported logging symptoms at least weekly. The most frequently desired features included tracking of specific symptoms (such as periods, pain, bowel symptoms, mental health symptoms), other tracking (such as medications and diet) and general app usability. Of those who use or would consider using an app 77.7% reported they would be comfortable sharing data with clinicians, and 76.1% reported they would be comfortable sharing anonymous data with researchers. Discussion: Almost half of participants reported using an app to track symptoms, and almost all reported they would consider use. Around three in four patients would be willing to share this data with clinicians and researchers, and therefore further focus on the utility of these apps may benefit patients directly, their relationship with healthcare providers and be utilised for further endometriosis research.


  • Experiences implementing hydrocolloid dressings after caesarean section

    by Simon M Scheck, Sikhar Sircar

    Aim: Despite increasing interest in reduction of surgical site infection (SSI) after caesarean section, there is limited evidence around optimal dressing choice. We report the experience of a secondary hospital in regional New Zealand changing from a basic contact dressing to a hydrocolloid dressing over a three-month period, reporting SSI rates, midwifery and nursing experience, and cost. Method: A retrospective cohort study of hydrocolloid dressings for caesarean sections over three months, compared with basic contact dressings in caesarean sections in the same period one year previously. We report wound swabs with significant growth; results from a survey sent to midwifery and nursing staff; and cost per dressing, as well as the number of dressing changes before discharge. Results: In the hydrocolloid group (n=94) four patients had significant growth on wound swabs (4.3%, 95% confidence interval CI): 0-10.6%) compared with six patients in the basic contact group (n=117) (5.1%, 95% CI: 1.0-7.1%). Only 9/20 (45%) midwives reported that they liked the hydrocolloid dressings, compared with 19/21 (90%) liking the basic contact dressings, primarily due to difficulty removing the dressings. When accounting for the number of dressing changes on the ward, the cost per caesarean section was $5.11 NZD for hydrocolloid dressings, compared with $5.72 NZD for basic contact dressings. Conclusion: Our initial experience with a change to hydrocolloid dressings showed promising results with regard to SSI rates, as well as a cost reduction. This, however, is to be balanced with dressings that are potentially more difficult to remove, resulting in reduced midwifery and nursing satisfaction. Declaration of interest: The authors have no financial or other disclosures or conflicts of interest to declare.


  • Five‐year follow‐up after cervical cytology and histology discordance: A retrospective cohort study

    by Simon M. Scheck, Catherine Liddle, Zoë Wood, Bruce Lockett, Sikhar Sircar

    Background: Cervical smear cytology and colposcopic biopsy histology are prone to error at both collection and interpretation stages, leading to a large number of discordant cases.Aims: Investigation of five‐year outcomes for women who have cervical cytology that is discordant and higher grade than histology results.Materials and Methods: A retrospective cohort study was carried out for 111 women with cervical cytology discordant and higher grade than histology, after cytopathological review, over a three‐year period. Five‐year follow‐up data were reviewed to identify the highest level of pathology seen within five years from the discordance.Results: Women with atypical squamous cells with possible high‐grade change (ASC‐H) cytology and negative biopsy (n = 28) had a 46% chance of high‐grade histological disease within 5 years; with cervical intraepithelial neoplasia grade 1 (CIN1) histology (n = 20), this was reduced to 30%. With high‐grade cytology and negative histology (n = 23), 48% had high‐grade disease within five years, including one case of invasive disease; with CIN1 histology 50% had high‐grade disease within five years.Conclusions: This study demonstrates a 30–50% chance of high‐grade disease within five years, in the setting of ASC‐H or high‐grade cytology with a negative or low‐grade colposcopic biopsy. This highlights that in the setting of cytology and histology discordance, at least one of the tests indicating high‐grade pathology warrants the need for treatment or close ongoing surveillance.


  • Cytopathological review of cervical pathology: Impact for women and follow-up results

    by Simon M. Scheck, Sam J. Lepine, Helen Yu, Olivia Robb, Peter Fitzgerald, Howard Clentworth, Dushyant Maharaj, Linda Tully, Amanda Tristram

    BackgroundCervical screening programs have had an important effect on the reduction of cervical cancer rates. Comprehensive programs require access to pathological review to improve the sensitivity of screening cytology and the specificity of diagnostic histology. AimsTo determine the number of cases where cervical cytology or histology was amended at cytopathological review; whether amendments were 'upgrades' or 'downgrades', and how amendments aligned with follow-up results for these patients. Materials and MethodsA retrospective cohort study was performed of all patients reviewed from January 2016 to December 2017 (n = 287 cases, from 254 patients) at colposcopy multidisciplinary meetings at Wellington Hospital, a tertiary referral hospital. Where amendments to cytology or histology were made, follow-up results were retrieved where available (85.7% and 84.2% respectively). ResultsCytology or histology was amended in 24.7% of cases. Smear cytology was amended in 16.7%. Where cytology was upgraded (n = 9), 44% had subsequent results of equal or higher grade including one case of adenocarcinoma. Where cytology was downgraded (n = 19), 93.8% (81.9-100%) had follow-up studies showing equal or lower results. Cervical biopsy histology was amended in 12.2% of cases (upgraded n = 19, downgraded n = 6). Large loop excision of the transformation zone or cone biopsy histology was amended in three cases (7.9%). ConclusionsCytopathological review appears to improve the specificity of the comprehensive cervical screening program, leading to a reduction in unnecessary treatment. Additionally, a small number of cases of malignant or premalignant disease were detected.


    • 20 September 2019
      • Vol. 132  (1502) , 11-15

    Cardiac disease in pregnancy and the multidisciplinary team: the Wellington experience

    by Simon M. Scheck, Sam Lepine, Olivia Nicholson, Peter Abels, Andrew Aitken

    AIM: To define the range and severity of cardiac disease in pregnant women in New Zealand, as well as the maternal and neonatal morbidity and mortality compared with the background obstetric population. METHODS: We retrospectively audited pregnant women with cardiac comorbidity seen by a multidisciplinary team at a tertiary referral centre consisting of midwives, cardiologists, obstetricians and anaesthetists in 2016-2017. RESULTS: Seventy-two women were referred to the multidisciplinary team. The most common referral reasons were arrhythmia (n=20, 27.8%), congenital anomalies (n=19, 26.4%) and palpitations (n=10, 13.9%). Fifty-two of these women were found to be at increased risk of morbidity or mortality. A specific delivery plan was devised for 37 of these women (69.8%). There was no serious maternal morbidity or mortality. Instrumental delivery rates were higher for women with cardiac comorbidity than the background obstetric population (19.2% vs 10.8%, p=0.049), however, neonatal admissions were not increased (11.5% compared with 16.5%). CONCLUSION: Multidisciplinary review of obstetric patients with cardiac disease provides an important service to ensure risk modification prior to conception and throughout pregnancy and the puerperium.

  • Caesarean section wound infection surveillance: Information for action

    by Simon M. Scheck, Timothy Blackmore, Dushyant Maharaj, Fali Langdana, Rosalie E. Elder

    Surgical site infection (SSI) following caesarean section is common, resulting in significant morbidity. Several factors are known to contribute to wound infection, including maternal, procedural and antibiotic factors. We sought to clarify these issues and sought opportunities to make improvements. A retrospective cohort study was performed assessing all women who underwent caesarean section in 2014 and 2015 at Wellington Hospital. Any women with culture‐positive wound samples within 30 days of surgery were identified, and clinical notes reviewed. Odds ratios (OR) were calculated for available maternal, procedural and antibiotic risk factors. Two simplified surveillance techniques were also tested for their abilities to identify significant trends. The study included 2231 women, of whom 116 (5.2%) were identified as having SSI. Maternal obesity (body mass index (BMI) ≥ 30) was associated with significant SSI risk (OR 4.1, P < 0.001). The pathogen distribution was significantly different between women with BMI < 30 and BMI ≥ 30 (P < 0.001). Increased cefazolin dose based on BMI (3 g dose for BMI ≥ 30) was associated with a significant reduction in SSI (OR 0.309, P < 0.001) and was administered in 74.1% of obese women receiving cefazolin. Māori women had an increased SSI risk (OR 2.1, P = 0.019), as did Samoan women (OR 3.0, P = 0.002). The study reinforces other studies showing that raised BMI is the single biggest risk factor for surgical site infection post‐caesarean section. Surveillance using simplified techniques appears to be adequate to identify trends. We believe that concentrating on appropriate antibiotic dosing and targeting special wound care measures will be pivotal interventions in improving outcomes in high‐risk groups.